Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Manzano

Showing results (151-160 of 179) with videos related to

Pageof 18
Sort By:
Revista Clinica Espanola|November 29, 2024
Failure of LDL-C goals achievement and underuse of lipid-lowering therapies in patients at high and very high cardiovascular risk: Spanish subset from the European SANTORINI studyJ M Mostaza, L García-Ortiz, M A Suárez Tembra, et al.
Revista Clinica Espanola|August 26, 2015
Reduction in hospitalisations and emergency department visits for frail patients with heart failure: Results of the UMIPIC healthcare programmeJ M Cerqueiro, A González-Franco, M Montero-Pérez-Barquero, et al.
ESMO Open|May 1, 2026
Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitorsJ Ros, M C de Grandis, V Navarro, et al.
Plos One|September 13, 2017
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin studyMaría Buti, María L Manzano, Rosa M Morillas, et al.
Plos One|June 26, 2018
Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin studyMaría Buti, María L Manzano, Rosa M Morillas, et al.
Antioxidants (Basel, Switzerland)|May 27, 2026
Inhibition of EPAC1 Prevents Neuronal Death Mediated by Diesel Exhaust Particles in Ferroptotic Cell Death ConditionsHong Yan, Leshan Zhang, Ana L Manzano-Covarrubias, et al.
Revista Clinica Espanola|April 13, 2016
Consensus for improving the comprehensive care of patients with acute heart failure: summarised versionN Manito Lorite, L Manzano Espinosa, P Llorens Soriano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2017
Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trialA Abad, E Martínez-Balibrea, J M Viéitez, et al.
Melanoma Research|February 27, 2018
Early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapyMaria Gonzalez-Cao, Clara Mayo de Las Casas, Nuria Jordana Ariza, et al.
Gastroenterologia Y Hepatologia|June 15, 2021
Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE StudyJuan Turnes, Diego Rincón, José L Calleja, et al.
Pageof 18

Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
Revista Clinica Espanola|November 29, 2024
Failure of LDL-C goals achievement and underuse of lipid-lowering therapies in patients at high and very high cardiovascular risk: Spanish subset from the European SANTORINI studyJ M Mostaza, L García-Ortiz, M A Suárez Tembra, et al.
Revista Clinica Espanola|August 26, 2015
Reduction in hospitalisations and emergency department visits for frail patients with heart failure: Results of the UMIPIC healthcare programmeJ M Cerqueiro, A González-Franco, M Montero-Pérez-Barquero, et al.
ESMO Open|May 1, 2026
Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitorsJ Ros, M C de Grandis, V Navarro, et al.
Plos One|September 13, 2017
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin studyMaría Buti, María L Manzano, Rosa M Morillas, et al.
Plos One|June 26, 2018
Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin studyMaría Buti, María L Manzano, Rosa M Morillas, et al.
Antioxidants (Basel, Switzerland)|May 27, 2026
Inhibition of EPAC1 Prevents Neuronal Death Mediated by Diesel Exhaust Particles in Ferroptotic Cell Death ConditionsHong Yan, Leshan Zhang, Ana L Manzano-Covarrubias, et al.
Revista Clinica Espanola|April 13, 2016
Consensus for improving the comprehensive care of patients with acute heart failure: summarised versionN Manito Lorite, L Manzano Espinosa, P Llorens Soriano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2017
Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trialA Abad, E Martínez-Balibrea, J M Viéitez, et al.
Melanoma Research|February 27, 2018
Early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapyMaria Gonzalez-Cao, Clara Mayo de Las Casas, Nuria Jordana Ariza, et al.
Gastroenterologia Y Hepatologia|June 15, 2021
Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE StudyJuan Turnes, Diego Rincón, José L Calleja, et al.
Pageof 18